AIM ImmunoTech Inc (AIM)
0.2117
+0.01
(+5.85%)
USD |
NYAM |
Nov 21, 16:00
0.2115
0.00 (0.00%)
After-Hours: 20:00
AIM ImmunoTech Profit Margin (Quarterly): -10.57K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -10.57K% |
| June 30, 2024 | -3.67K% |
| March 31, 2024 | -14.54K% |
| December 31, 2023 | -19.35K% |
| September 30, 2023 | -16.99K% |
| June 30, 2023 | -11.69K% |
| March 31, 2023 | -7.47K% |
| December 31, 2022 | -7.84K% |
| September 30, 2022 | -30.40K% |
| June 30, 2022 | -16.17K% |
| March 31, 2022 | -11.58K% |
| December 31, 2021 | -11.69K% |
| September 30, 2021 | -11.59K% |
| June 30, 2021 | -25.55K% |
| March 31, 2021 | -12.78K% |
| December 31, 2020 | -9.37K% |
| September 30, 2020 | -9.18K% |
| June 30, 2020 | -8.42K% |
| March 31, 2020 | -8.46K% |
| December 31, 2019 | -2.13K% |
| September 30, 2019 | -4.83K% |
| June 30, 2019 | -7.02K% |
| March 31, 2019 | |
| December 31, 2018 | -675.4% |
| September 30, 2018 | -8.10K% |
| Date | Value |
|---|---|
| June 30, 2018 | -7.32K% |
| March 31, 2018 | -4.84K% |
| December 31, 2017 | -3.99K% |
| September 30, 2017 | -1.39K% |
| June 30, 2017 | -1.03K% |
| March 31, 2017 | -3.36K% |
| December 31, 2016 | -7.33K% |
| September 30, 2016 | -13.01K% |
| June 30, 2016 | -8.69K% |
| March 31, 2016 | -5.55K% |
| December 31, 2015 | -11.62K% |
| September 30, 2015 | -16.53K% |
| June 30, 2015 | -10.31K% |
| March 31, 2015 | -9.57K% |
| December 31, 2014 | -11.14K% |
| September 30, 2014 | -9.34K% |
| June 30, 2014 | -13.77K% |
| March 31, 2014 | -5.05K% |
| December 31, 2013 | -8.88K% |
| September 30, 2013 | -14.27K% |
| June 30, 2013 | -11.90K% |
| March 31, 2013 | -8.60K% |
| December 31, 2012 | -10.30K% |
| September 30, 2012 | -16.89K% |
| June 30, 2012 | -6.12K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-30.40K%
Minimum
Sep 2022
-2.13K%
Maximum
Dec 2019
-12.47K%
Average
-11.58K%
Median
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 18.02% |
| Electromed Inc | 10.05% |
| Xtant Medical Holdings Inc | -17.98% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -256.3% |
| Return on Assets | -129.0% |
| Return on Invested Capital | -219.1% |
| Gross Profit Margin (Quarterly) | 77.14% |
| Operating Margin (Quarterly) | -12.83K% |
| Return on Net Operating Assets | -696.3% |